EP
TERN

Essential Partners’s Terns Pharmaceuticals TERN Stock Holding History

Essential Partners’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$422 – 2957
2026
Q1 		$422 Hold
8
– – ﹤0.01% 2484
2025
Q4 		$323 Hold
8
– – ﹤0.01% 2322
2025
Q3 		$60 Hold
8
– – ﹤0.01% 2548
2025
Q2 		$30 Buy
+8
New +$25 ﹤0.01% 2196

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Essential Partners's TERN Position: Q2 2026 in Review

Essential Partners sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 8 shares — an estimated $422 sold.

Essential Partners first reported a position in TERN in Q2 2025 and held it in 4 quarters. The position peaked at $422 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Essential Partners reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Essential Partners sold 8 Terns Pharmaceuticals shares in Q2 2026, an estimated $422.
  • Essential Partners first reported a position in Terns Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • Essential Partners's Terns Pharmaceuticals position peaked at $422 in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.